Bringing people back to HIV care and keeping them on treatment in Zambia
Sequential Strategies to Reach and Reengage Individuals after Lapses from HIV Care in Zambia
This project tests whether personalized outreach navigators plus community medication delivery can help people in Zambia who stopped HIV care return and stay on antiretroviral treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11166323 on NIH RePORTER |
What this research studies
If you have missed HIV treatment visits in Zambia, this project focuses on getting you back into care and preventing future lapses. It compares and combines two approaches: trained navigators who tailor outreach, care coordination, and psychosocial support, and delivering HIV medicines in the community to make access easier. Participants who return to care will be followed to see which timing and combinations of services best prevent repeat lapses. The team will use person-centered outreach and community-based medication delivery across study sites in Zambia to find practical ways to keep people engaged in treatment.
Who could benefit from this research
Good fit: Ideal candidates are people in Zambia living with HIV who have missed appointments or stopped antiretroviral therapy and are willing to be contacted for outreach and community medication delivery.
Not a fit: People who are already consistently in HIV care and virally suppressed, or those living outside the study communities in Zambia, are unlikely to receive direct benefit from participation.
Why it matters
Potential benefit: If successful, this could help more people resume HIV treatment, keep viral loads suppressed, and reduce hospitalizations and deaths.
How similar studies have performed: Navigation and community-based medication delivery have improved outcomes for new or stable ART patients in earlier work, but combining and sequencing these approaches for people with treatment lapses is relatively untested.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Mody, Aaloke — Washington University
- Study coordinator: Mody, Aaloke
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.